Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery
Yishun Yang,1 Yuan Zhao,2 Jinshuai Lan,1 Yanan Kang,3 Tong Zhang,1 Yue Ding,1 Xinyu Zhang,1 Lu Lu3 1Experiment Centre of Teaching and Learning, Shanghai University of Traditional Chinese Medicine, Shanghai, China; 2Experiment Centre for Science and Technology, Shanghai University of Traditional Chi...
Main Authors: | Yang YS, Zhao Y, Lan JS, Kang YN, Zhang T, Ding Y, Zhang XY, Lu L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-07-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/reduction-sensitive-cd44-receptor-targeted-hyaluronic-acid-derivative--peer-reviewed-article-IJN |
Similar Items
-
Computational approach to the design of hyaluronic acid copolymer based doxorubicin micelles
by: Yujiao Sun, et al.
Published: (2016-02-01) -
The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin
by: Wang J, et al.
Published: (2016-11-01) -
Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System
by: Tao Yu, et al.
Published: (2020-08-01) -
Hyaluronic Acid-Decorated Laponite® Nanocomposites for Targeted Anticancer Drug Delivery
by: Tingting Jiang, et al.
Published: (2019-01-01) -
Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer
by: Zhou YF, et al.
Published: (2017-08-01)